Pharma & Healthcare
Global Diagnostic Radiopharmaceuticals Market Research Report 2024
- Sep 27, 24
- ID: 52039
- Pages: 91
- Figures: 93
- Views: 12
Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.
Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.
In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.
The global Diagnostic Radiopharmaceuticals market was valued at US$ 5050 million in 2023 and is anticipated to reach US$ 8059 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.
One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.
North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals.
The Diagnostic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Diagnostic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
Segment by Type
Technetium 99
Fluorine 18
Other
Segment by Application
Oncology
Cardiology
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.
In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.
The global Diagnostic Radiopharmaceuticals market was valued at US$ 5050 million in 2023 and is anticipated to reach US$ 8059 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.
One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.
North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals.
The Diagnostic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Diagnostic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
Segment by Type
Technetium 99
Fluorine 18
Other
Segment by Application
Oncology
Cardiology
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Diagnostic Radiopharmaceuticals Market Overview
1.1 Product Definition
1.2 Diagnostic Radiopharmaceuticals by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Market Value by Application (2024-2030)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2019-2030
1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2019-2030
1.4.3 Global Diagnostic Radiopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diagnostic Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Diagnostic Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
2.7 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
2.8 Global Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
2.8.1 Global Diagnostic Radiopharmaceuticals Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
2.8.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diagnostic Radiopharmaceuticals Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diagnostic Radiopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Diagnostic Radiopharmaceuticals Sales by Region: 2025-2030
3.3 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
3.6.1 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2019-2030)
3.6.3 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Diagnostic Radiopharmaceuticals Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Diagnostic Radiopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Company Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Jubilant Pharma
6.3.1 Jubilant Pharma Company Information
6.3.2 Jubilant Pharma Description and Business Overview
6.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.3.5 Jubilant Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Diagnostic Radiopharmaceuticals Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Curium Pharma
6.5.1 Curium Pharma Company Information
6.5.2 Curium Pharma Description and Business Overview
6.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.5.5 Curium Pharma Recent Developments/Updates
6.6 SIEMENS
6.6.1 SIEMENS Company Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
6.6.5 SIEMENS Recent Developments/Updates
6.7 Lantheus
6.7.1 Lantheus Company Information
6.7.2 Lantheus Description and Business Overview
6.7.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Bracco Imaging
6.8.1 Bracco Imaging Company Information
6.8.2 Bracco Imaging Description and Business Overview
6.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
6.8.5 Bracco Imaging Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Company Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 China Isotope & Radiation
6.10.1 China Isotope & Radiation Company Information
6.10.2 China Isotope & Radiation Description and Business Overview
6.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
6.10.5 China Isotope & Radiation Recent Developments/Updates
6.11 Dongcheng
6.11.1 Dongcheng Company Information
6.11.2 Dongcheng Description and Business Overview
6.11.3 Dongcheng Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dongcheng Diagnostic Radiopharmaceuticals Product Portfolio
6.11.5 Dongcheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
7.2 Diagnostic Radiopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Radiopharmaceuticals Production Mode & Process
7.4 Diagnostic Radiopharmaceuticals Sales and Marketing
7.4.1 Diagnostic Radiopharmaceuticals Sales Channels
7.4.2 Diagnostic Radiopharmaceuticals Distributors
7.5 Diagnostic Radiopharmaceuticals Customers
8 Diagnostic Radiopharmaceuticals Market Dynamics
8.1 Diagnostic Radiopharmaceuticals Industry Trends
8.2 Diagnostic Radiopharmaceuticals Market Drivers
8.3 Diagnostic Radiopharmaceuticals Market Challenges
8.4 Diagnostic Radiopharmaceuticals Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Diagnostic Radiopharmaceuticals by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Market Value by Application (2024-2030)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2019-2030
1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2019-2030
1.4.3 Global Diagnostic Radiopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diagnostic Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Diagnostic Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
2.7 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
2.8 Global Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
2.8.1 Global Diagnostic Radiopharmaceuticals Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
2.8.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diagnostic Radiopharmaceuticals Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diagnostic Radiopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Diagnostic Radiopharmaceuticals Sales by Region: 2025-2030
3.3 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
3.6.1 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2019-2030)
3.6.3 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Diagnostic Radiopharmaceuticals Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Diagnostic Radiopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Company Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Jubilant Pharma
6.3.1 Jubilant Pharma Company Information
6.3.2 Jubilant Pharma Description and Business Overview
6.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.3.5 Jubilant Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Diagnostic Radiopharmaceuticals Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Curium Pharma
6.5.1 Curium Pharma Company Information
6.5.2 Curium Pharma Description and Business Overview
6.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.5.5 Curium Pharma Recent Developments/Updates
6.6 SIEMENS
6.6.1 SIEMENS Company Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
6.6.5 SIEMENS Recent Developments/Updates
6.7 Lantheus
6.7.1 Lantheus Company Information
6.7.2 Lantheus Description and Business Overview
6.7.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Bracco Imaging
6.8.1 Bracco Imaging Company Information
6.8.2 Bracco Imaging Description and Business Overview
6.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
6.8.5 Bracco Imaging Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Company Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 China Isotope & Radiation
6.10.1 China Isotope & Radiation Company Information
6.10.2 China Isotope & Radiation Description and Business Overview
6.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
6.10.5 China Isotope & Radiation Recent Developments/Updates
6.11 Dongcheng
6.11.1 Dongcheng Company Information
6.11.2 Dongcheng Description and Business Overview
6.11.3 Dongcheng Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dongcheng Diagnostic Radiopharmaceuticals Product Portfolio
6.11.5 Dongcheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
7.2 Diagnostic Radiopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Radiopharmaceuticals Production Mode & Process
7.4 Diagnostic Radiopharmaceuticals Sales and Marketing
7.4.1 Diagnostic Radiopharmaceuticals Sales Channels
7.4.2 Diagnostic Radiopharmaceuticals Distributors
7.5 Diagnostic Radiopharmaceuticals Customers
8 Diagnostic Radiopharmaceuticals Market Dynamics
8.1 Diagnostic Radiopharmaceuticals Industry Trends
8.2 Diagnostic Radiopharmaceuticals Market Drivers
8.3 Diagnostic Radiopharmaceuticals Market Challenges
8.4 Diagnostic Radiopharmaceuticals Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Diagnostic Radiopharmaceuticals Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Diagnostic Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2023
Table 4. Global Diagnostic Radiopharmaceuticals Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Diagnostic Radiopharmaceuticals Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Diagnostic Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
Table 12. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diagnostic Radiopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (K Dose)
Table 18. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 19. Global Diagnostic Radiopharmaceuticals Sales by Region (2025-2030) & (K Dose)
Table 20. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2025-2030)
Table 21. Global Diagnostic Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 23. Global Diagnostic Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2025-2030)
Table 25. North America Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 27. North America Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 28. North America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Diagnostic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Type (2019-2024)
Table 51. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Type (2025-2030)
Table 52. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Table 53. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2025-2030)
Table 54. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
Table 57. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2025-2030)
Table 58. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Type (2019-2024)
Table 59. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Type (2025-2030)
Table 60. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Application (2019-2024)
Table 61. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Application (2025-2030)
Table 62. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Table 63. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2025-2030)
Table 64. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2024)
Table 67. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2025-2030)
Table 68. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Application (2019-2024)
Table 69. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Application (2025-2030)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 74. Cardinal Health Recent Developments/Updates
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. GE Healthcare Diagnostic Radiopharmaceuticals Product
Table 79. GE Healthcare Recent Developments/Updates
Table 80. Jubilant Pharma Company Information
Table 81. Jubilant Pharma Description and Business Overview
Table 82. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Jubilant Pharma Diagnostic Radiopharmaceuticals Product
Table 84. Jubilant Pharma Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Novartis Diagnostic Radiopharmaceuticals Product
Table 89. Novartis Recent Developments/Updates
Table 90. Curium Pharma Company Information
Table 91. Curium Pharma Description and Business Overview
Table 92. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Curium Pharma Diagnostic Radiopharmaceuticals Product
Table 94. Curium Pharma Recent Developments/Updates
Table 95. SIEMENS Company Information
Table 96. SIEMENS Description and Business Overview
Table 97. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. SIEMENS Diagnostic Radiopharmaceuticals Product
Table 99. SIEMENS Recent Developments/Updates
Table 100. Lantheus Company Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Lantheus Diagnostic Radiopharmaceuticals Product
Table 104. Lantheus Recent Developments/Updates
Table 105. Bracco Imaging Company Information
Table 106. Bracco Imaging Description and Business Overview
Table 107. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Bracco Imaging Diagnostic Radiopharmaceuticals Product
Table 109. Bracco Imaging Recent Developments/Updates
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Eli Lilly Diagnostic Radiopharmaceuticals Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. China Isotope & Radiation Company Information
Table 116. China Isotope & Radiation Description and Business Overview
Table 117. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product
Table 119. China Isotope & Radiation Recent Developments/Updates
Table 120. Dongcheng Company Information
Table 121. Dongcheng Description and Business Overview
Table 122. Dongcheng Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Dongcheng Diagnostic Radiopharmaceuticals Product
Table 124. Dongcheng Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Diagnostic Radiopharmaceuticals Distributors List
Table 128. Diagnostic Radiopharmaceuticals Customers List
Table 129. Diagnostic Radiopharmaceuticals Market Trends
Table 130. Diagnostic Radiopharmaceuticals Market Drivers
Table 131. Diagnostic Radiopharmaceuticals Market Challenges
Table 132. Diagnostic Radiopharmaceuticals Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals
Figure 2. Global Diagnostic Radiopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diagnostic Radiopharmaceuticals Market Share by Type: 2023 & 2030
Figure 4. Technetium 99 Product Picture
Figure 5. Fluorine 18 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Diagnostic Radiopharmaceuticals Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Diagnostic Radiopharmaceuticals Market Share by Application: 2023 & 2030
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Diagnostic Radiopharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Diagnostic Radiopharmaceuticals Market Size (2019-2030) & (US$ Million)
Figure 14. Global Diagnostic Radiopharmaceuticals Sales (2019-2030) & (K Dose)
Figure 15. Global Diagnostic Radiopharmaceuticals Average Price (US$/Dose) & (2019-2030)
Figure 16. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 17. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2023
Figure 18. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players: Market Share by Revenue in Diagnostic Radiopharmaceuticals in 2023
Figure 20. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Diagnostic Radiopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 23. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 27. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
Figure 28. Germany Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
Figure 35. China Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 46. Mexico Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2019-2030)
Figure 55. Global Revenue Market Share of Diagnostic Radiopharmaceuticals by Type (2019-2030)
Figure 56. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Type (2019-2030)
Figure 57. Global Sales Market Share of Diagnostic Radiopharmaceuticals by Application (2019-2030)
Figure 58. Global Revenue Market Share of Diagnostic Radiopharmaceuticals by Application (2019-2030)
Figure 59. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Application (2019-2030)
Figure 60. Diagnostic Radiopharmaceuticals Value Chain
Figure 61. Diagnostic Radiopharmaceuticals Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Diagnostic Radiopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Diagnostic Radiopharmaceuticals Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Diagnostic Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2023
Table 4. Global Diagnostic Radiopharmaceuticals Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Diagnostic Radiopharmaceuticals Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Diagnostic Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
Table 12. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diagnostic Radiopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (K Dose)
Table 18. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 19. Global Diagnostic Radiopharmaceuticals Sales by Region (2025-2030) & (K Dose)
Table 20. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2025-2030)
Table 21. Global Diagnostic Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 23. Global Diagnostic Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2025-2030)
Table 25. North America Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 27. North America Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 28. North America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Diagnostic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Type (2019-2024)
Table 51. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Type (2025-2030)
Table 52. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Table 53. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2025-2030)
Table 54. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
Table 57. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2025-2030)
Table 58. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Type (2019-2024)
Table 59. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Type (2025-2030)
Table 60. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Application (2019-2024)
Table 61. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Application (2025-2030)
Table 62. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Table 63. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2025-2030)
Table 64. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2024)
Table 67. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2025-2030)
Table 68. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Application (2019-2024)
Table 69. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Application (2025-2030)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 74. Cardinal Health Recent Developments/Updates
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. GE Healthcare Diagnostic Radiopharmaceuticals Product
Table 79. GE Healthcare Recent Developments/Updates
Table 80. Jubilant Pharma Company Information
Table 81. Jubilant Pharma Description and Business Overview
Table 82. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Jubilant Pharma Diagnostic Radiopharmaceuticals Product
Table 84. Jubilant Pharma Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Novartis Diagnostic Radiopharmaceuticals Product
Table 89. Novartis Recent Developments/Updates
Table 90. Curium Pharma Company Information
Table 91. Curium Pharma Description and Business Overview
Table 92. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Curium Pharma Diagnostic Radiopharmaceuticals Product
Table 94. Curium Pharma Recent Developments/Updates
Table 95. SIEMENS Company Information
Table 96. SIEMENS Description and Business Overview
Table 97. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. SIEMENS Diagnostic Radiopharmaceuticals Product
Table 99. SIEMENS Recent Developments/Updates
Table 100. Lantheus Company Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Lantheus Diagnostic Radiopharmaceuticals Product
Table 104. Lantheus Recent Developments/Updates
Table 105. Bracco Imaging Company Information
Table 106. Bracco Imaging Description and Business Overview
Table 107. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Bracco Imaging Diagnostic Radiopharmaceuticals Product
Table 109. Bracco Imaging Recent Developments/Updates
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Eli Lilly Diagnostic Radiopharmaceuticals Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. China Isotope & Radiation Company Information
Table 116. China Isotope & Radiation Description and Business Overview
Table 117. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product
Table 119. China Isotope & Radiation Recent Developments/Updates
Table 120. Dongcheng Company Information
Table 121. Dongcheng Description and Business Overview
Table 122. Dongcheng Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Dongcheng Diagnostic Radiopharmaceuticals Product
Table 124. Dongcheng Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Diagnostic Radiopharmaceuticals Distributors List
Table 128. Diagnostic Radiopharmaceuticals Customers List
Table 129. Diagnostic Radiopharmaceuticals Market Trends
Table 130. Diagnostic Radiopharmaceuticals Market Drivers
Table 131. Diagnostic Radiopharmaceuticals Market Challenges
Table 132. Diagnostic Radiopharmaceuticals Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals
Figure 2. Global Diagnostic Radiopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diagnostic Radiopharmaceuticals Market Share by Type: 2023 & 2030
Figure 4. Technetium 99 Product Picture
Figure 5. Fluorine 18 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Diagnostic Radiopharmaceuticals Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Diagnostic Radiopharmaceuticals Market Share by Application: 2023 & 2030
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Diagnostic Radiopharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Diagnostic Radiopharmaceuticals Market Size (2019-2030) & (US$ Million)
Figure 14. Global Diagnostic Radiopharmaceuticals Sales (2019-2030) & (K Dose)
Figure 15. Global Diagnostic Radiopharmaceuticals Average Price (US$/Dose) & (2019-2030)
Figure 16. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 17. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2023
Figure 18. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players: Market Share by Revenue in Diagnostic Radiopharmaceuticals in 2023
Figure 20. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Diagnostic Radiopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 23. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 27. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
Figure 28. Germany Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
Figure 35. China Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 46. Mexico Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Diagnostic Radiopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2019-2030)
Figure 55. Global Revenue Market Share of Diagnostic Radiopharmaceuticals by Type (2019-2030)
Figure 56. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Type (2019-2030)
Figure 57. Global Sales Market Share of Diagnostic Radiopharmaceuticals by Application (2019-2030)
Figure 58. Global Revenue Market Share of Diagnostic Radiopharmaceuticals by Application (2019-2030)
Figure 59. Global Diagnostic Radiopharmaceuticals Price (US$/Dose) by Application (2019-2030)
Figure 60. Diagnostic Radiopharmaceuticals Value Chain
Figure 61. Diagnostic Radiopharmaceuticals Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232